GlassScriptPhysician profile
Harshini Avula
NPI 1518258896
$5,436.62
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.58 · 2021: $31.24 · 2022: $5,171 · 2023: $22.81 · 2024: $40.15 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,818.37 | 2022 | |
| Paragon 28, INC. | $1,596.28 | 2022 | |
| Arthrex, INC. | $1,478.08 | 2022 | |
| Abbvie INC. | $136.30 | 2022 | |
| Organogenesis INC. | $125.00 | 2022 | |
| Stryker Corporation | $90.75 | 2019-2022 | |
| Treace Medical Concepts, INC. | $66.39 | 2025 | |
| Amgen INC. | $51.48 | 2025 | Krystexxa |
| Abbott Laboratories | $42.43 | 2023-2024 | Proclaim |
| Paratek Pharmaceuticals, INC. | $20.53 | 2024 | Nuzyra |
| Wright Medical Technology, INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harshini Avula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.